A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study.
Saved in:
| Title: | A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study. |
|---|---|
| Authors: | Sharon JD; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Krauter R; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Chae R; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Gardi A; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Hum M; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Allen I; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Levin M; Department of Neurology, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Headache [Headache] 2024 Nov-Dec; Vol. 64 (10), pp. 1264-1272. Date of Electronic Publication: 2024 Sep 30. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
